Patient Presentation: A 23-year-old obese female was diagnosed with idiopathic intracranial hypertension (IIH) and referred to neurosurgery for ventriculoperitoneal shunt. A baseline ocular examination was performed prior to the procedure.
On examination, vision was 20/200 in the right eye, and 20/40 in the left eye. There was a right relative afferent pupillary defect. Slit lamp examination was normal.
A dilated fundus examination was performed demonstrating the following:
Neuro-Ophthalmology
Case 25
Contributor: Arshia Eshtiaghi (CC3)
Patient Presentation: A 35-year old woman presented to a tertiary ophthalmology clinic with progressive bilateral vision loss over the past 3 months. Her mother and uncle had experienced a similar loss of vision many years ago. Her vision on presentation was 20/200 OD and 20/70 OS. IOP was 13 OD and 12 OS; there was no RAPD. Humphrey visual field (24-2) testing was performed and shown below:
Fundus imaging alongside OCT ganglion cell and RNFL analysis was also performed and is shown below:
Question 1: How would you describe the visual field defects above?
Question 2: Given the pattern of visual field loss, what is the differential diagnosis?
One year later, OCT ganglion cell and RNFL analysis was conducted and is shown below:
Question 3: What is the interpretation of the above OCT images?
Question 4: What is the most likely diagnosis?
Question 5: What is the most common gene implicated in Leber's Hereditary Optic Neuropathy?
References:
-
Steven A Newman; Cecocentral Scotoma: A Neuro-Ophthalmic Revisionist Approach. Invest. Ophthalmol. Vis. Sci. 2015;56(7):2605.
-
Enright J, Van Stavern G. Application of optical coherence tomography in hereditary, toxic and metabolic optic neuropathies. Ann Eye Sci. 2020. doi:10.21037/aes.2020.02.04
-
Caporali L, Maresca A, Capristo M, et al. Incomplete penetrance in mitochondrial optic neuropathies. Mitochondrion. 2017. doi:10.1016/j.mito.2017.07.004
-
Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol. 2007.
-
Karaarslan C. Leber's Hereditary Optic Neuropathy as a Promising Disease for Gene Therapy Development. Advances in Therapy. 2019.
Learning Objectives:
-
To recognize the natural history, exam findings, and OCT features of LHON.
-
To distinguish the presentation of LHON from dominant optic atrophy.